42 nd Annual Post Graduate Radiology Course
Hotel Del Coronado • Coronado, California Thursday PM, October 19, 2017 TABLE OF CONTENTS
Thursday PM, October 19, 2017
Liver Logic: LI-RADS Why and How (Cynthia S. Santillan, M.D., FSAR)...... 591
What Lurks Below: Retroperitoneal Tumors & Diseases (Noushin Vahdat, M.D.)...... 601
Variant Vessels: Vascular Liver Abnormalities (Cynthia S. Santillan, M.D., FSAR)...... 617
Don’t Be Fooled: Mimickers of Disease in the Chest, Abdomen and Pelvis (Hamad Aryafar, M.D.)...... 623
Romneycare: Are We Learning from Healthcare Reform? (Alexander Norbash, M.D., M.S.)...... 643
Cold Foot? Peripheral Vascular Imaging for Diagnostic Radiologists (Hamed Aryafar, M.D.)...... 657
SAVE THE DATE - 2018 Fall Symposia 591 592 THIDs, THADs, THEDs Overview Vascular Liver Abnormalities Objectives To review the normal vascular supply and drainage of the liver
To discuss how abnormalities in blood flow can affect the enhancement pattern of the liver on CT and MRI
To review disease processes that affect the vessels of the liver, including thrombosis, tumor invasion, inflammation, and masses, Cynthia Santillan, MD and how to distinguish them from each University of California San Diego other
Vascular Supply & Drainage Normal
HV Liver receives 25% of cardiac output
Vascular Supply & Drainage Portal vein = PV 75% inflow
HA Hepatic artery = 25% inflow
Vascular Supply & Drainage Vascular Supply & Drainage Normal Normal
Hepatic Arterial Phase Portal Venous Phase HV HV HA enhanced Maximum parenchymal PV enhanced enhancement PV HV not enhanced PV HA & PV enhanced HA Parenchyma starting HA HV with antegrade to enhance enhancement
593 Vascular Supply & Drainage Vascular Supply & Drainage Normal Abnormal Hepatic Arterial Buffer Response
Delayed Venous Phase PV cannot self-regulate flow HV Progressive decreased HABR increases or decreases enhancement of all arterial inflow in response PV structures to portal flow alterations
HA Decreased Can compensate for 25-60% Portal Flow of decreased portal flow Normal
Hepatic Arterial Phase
Eipel et al, Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16:6046-57
Vascular Supply & Drainage Vascular Supply & Drainage Abnormal Abnormal Hepatic Arterial Buffer Response Hepatic Arterial Buffer Response
Triggers hepatorenal reflex Can worsen functional dearterialization Allows continued clearance of metabolites/chemicals Seen following large
Synthetic function closely resection or living related Decreased Increased donor/recipient tied to portal flow Portal Flow Portal Flow Oxygenation does not drive Associated with Normal response Normal Ischemic cholangitis Hepatic Arterial Phase Hepatic Arterial Phase Infarcts
Eipel et al, Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16:6046-57 Eipel et al, Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16:6046-57
Vascular Supply & Drainage Vascular Supply & Drainage Abnormal THID, THED, THAD Impaired Outflow Transient Hepatic Enhancement Difference
Congestion causes absent or Enhancement abnormality reversed peripheral portal flow that does not correspond to
Central liver & caudate an underlying mass/lesion & resolves on later imaging less affected due to Abnormal accessory venous Seen more frequently now drainage due to multiphase, fast imaging Normal Hepatic Arterial Phase Portal Venous Phase
594 Pre-hepatic Portal Vein Non-Cirrhotics Prothrombotic disorders
Cirrhotics Pre-Hepatic Thrombus occurs in up to 30% Low flow state Extent & chronicity must be reported in transplant candidates
Francoz et al, Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatology 2012; 57:203-12
Pre-hepatic Pre-hepatic Portal Vein Portal Vein
Non-enhancing portal Laminar Flow vein or branches Splenic return may Assess SMV & preferentially go to left lobe splenic vein Splenic vein enhances prior to Increased enhancement SMV of affected parenchyma in Inconsistent
arterial phase Can mimic thrombus Calcification implies Always confirm on venous chronic thrombus or delayed phases
Desser TS, Understanding transient hepatic attenuation differences. Semin Ultrasound CT MRI 2009; 30:408-17
Pre-hepatic Pre-hepatic Portal Vein Portal Vein Vascular Invasion Cavernous Transformation Increased Can occur as quickly as frequency 6 days after occlusion with tumors
Paracholedochal veins >5cm
& recanalized Indicative of channels in thrombus Tumor Stage 4b HCC
De Gaetano et al, Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected wit Doppler sonography, AJR 1995; 165:1151-55
595 Pre-hepatic Pre-hepatic Portal Vein Portal Vein Vascular Invasion Vascular Invasion Increased T2 signal within Thread and streak sign the vessel Visible during arterial Enhancement phase Blood vessels in & Expansile
around tumor Increased extending into portal signal on vein DWI
Bjorn-Werner R, The thread and streak sign, Radiology 2005; 236:284-85
Pre-hepatic Pre-hepatic Portal Vein Portal Vein Vascular Invasion Vascular Invasion
Previously thought Cholangiocarcinoma more often encases or that less than 5% displaces vessels rather than invading of fibrolamellar HCCs invade the portal vein
Newer data with large lesions suggests much higher rates of invasion
Pre-hepatic Superior Vena Cava Cavoportal Collateral Pathway
SVC epigastric/ mammary veins Intrahepatic recanalized paraumbilical vein portal vein
Hot Quadrate
Kapur et al, Where there is blood, there is a way: unusual collateral vessels in superior and sign inferior vena cava obstruction, Radiographics 2010; 30:67-78
596 Intrahepatic Intrahepatic Biliary Biliary Obstruction of the peribiliary Peribiliary plexus = plexus due to biliary dilation or mesh surrounding the inflammation bile ducts impairment of portal inflow
arterial compensation Accounts for some portal inflow to the Tends to be in a peribiliary parenchyma distribution when due to obstruction
Polymorphous pattern when inflammatory
Pradella et al, Transient hepatic attenuation difference (THAD) in biliary duct disease. Abdom Imaging 2009, 34: 626-33 Pradella et al, Transient hepatic attenuation difference (THAD) in biliary duct disease. Abdom Imaging 2009, 34: 626-33
Intrahepatic Intrahepatic Inflammation Inflammation Abscess Adjacent Structures Cholecystits Double target sign
Pancreatitis Increased capillary
Inflammation permeability Increased arterial induced hyperemia inflow Decreased portal Regional arterial inflow due to hyperperfusion edema Sump effect
Colagrande S et al, Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR 2007; 188:160-66 Colagrande S et al, Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR 2007; 188:160-66
Intrahepatic Intrahepatic Vascular Vascular AP shunts Signal Abnormalities
Cirrhosis Inc T2 signal due to inc Narrowed sinusoids portal free water hypertension enlarged Impaired hepatocellular peribiliary plexus & enlarged function arterial connections to Decreased sinusoids & portal veins
THED hepatocyte Interventions agent Direct connections uptake between arterial & Ahn et al, Nontumorous arterioportal shunts in the liver: CT and MRI Altered fat findings considering mechanisms and fate, Eur Radiol 2010; 20:385-94 portal systems Colagrande S et al, Transient hepatic intensity differences: part 2, those not associated with focal lesions. content AJR 2007; 188:160-66
597 Intrahepatic Intrahepatic Hereditary Hemorrhagic Hemangioma Telangiectasia
Arteriovenous & portovenous shunting Follow portal vein anatomy Enlarged hepatic arteries Wedge shaped Early venous filling
Torabi et al, CT of nonneoplastic hepatic vascular and perfusion Case courtesy of Christine Menias, MD disorders, Radiographics 2008; 28:1967-62
Intrahepatic Intrahepatic Hemangioma HCC A-P shunts are present in 60% of large HCCs Siphoning/sump effect HCCs often cause perfusion In lesions less than 3 cm, abnormalities due to more frequently due portal compression/ to benign lesions than invasion malignancy
Colagrande S et al, Transient hepatic attenuation differences and focal liver lesions: sump effect due to primary arterial hyperperfusion, J Comput Assist Tomogr 2009; 33:259-65
Intrahepatic HCC Perfusion abnormalities in patients with chronic liver disease require careful inspection of the apex to Post-hepatic: assess for HCC Hepatic Vein
598 Post-hepatic Post-hepatic Congestion Budd-Chiari Fan-shaped enhancement Patchy, heterogeneous enhancement Highly characteristic of acute disease Nutmeg liver Delayed peripheral enhancement Perivascular edema Reversed portal venous flow Enlarged hepatic veins, Edema IVC Central Hepatomegaly enhancement Chronic congestion preserved cirrhosis Gore et al, Passive hepatic congestion: cross sectional imaging features, AJR 1994;162:71-75 Torabi et al, CT of nonneoplastic hepatic vascular and perfusion disorders, Radiographics 2008; 28:1967-62
Post-hepatic Post-hepatic Budd-Chiari Budd-Chiari Flip-flop
Pattern may reverse in delayed Chronic
phase Hepatic veins Contrast cleared by central liver narrowed Stagnant contrast in periphery Peripheral Non-enhancement of hepatic veins atrophy Often markedly narrowed Comma-shaped
Hepatomegaly collateral vessels
Post-hepatic Budd-Chiari
Regenerative nodules
Begin to form within days of occlusion
Typically 1-4cm
Hyperenhancing
Resemble focal nodular hyperplasia when large
Do not “wash-out”
599 600 601 602 Overview WHAT LURKS BELOW: RETROPERITONEAL TUMORS Retroperitoneal Anatomy
AND DISEASES Cystic and Solid Non-Neoplastic Processes Noushin Vahdat, MD Tumors Associate Professor of Radiology
UCSD-VA Medical Center, San Diego
DIVIDED BY FASCIAL PLANES INTO:
Anatomy RETROPERITONEUM And Anterior Pararenal Space Spaces Posterior Pararenal Space
Perirenal or Perinephric(PRS) Space
PAIRED PERIRENAL SPACES ANATOMY AND SPACES
Two inverted cones, containing kidneys and adrenals, outlined by: Gerota fascia Renal forms by apposition of two layers of fascia: Zuckerkandl fascia Fascia and
Creating a potential space extending from anterior pararenal space Perirenal spaces communicate at the level of lower lumbar vertebra
603 ANTERIOR PARARENAL SPACE ANTERIOR PARARENAL SPACE
Confined by: Inferiorly below the kidneys, continuous with: Perirenal and Posterior Pararenal Pelvic Retroperitoneum
Contains: Ascending and Descending colon Robert E. Bechtold, RadioGraphics 1996; 16:811-85 (Pericolonic Component) Duodenum and Pancreas (Pancreaticoduodenal Component) PRS is open to diaphragm and the Retroperitoneal hematoma bare area of the liver Superiorly Continuous across the midline extending to pelvis
Hematoma POSTERIOR PARARENAL SPACE Urinoma
Bounded by: CYSTIC Lymphocele anteriorly posteriorly NONNEOPLASTIC Seroma
PROCESSES Abscess Medially limited by psoas muscle Pancreatic Laterally open toward the flank Pseudocyst, Inferionly open to pelvis Pancreatic or Peripancreatic Contains fat Necrosis
IMAGING HEMATOMA
CT - Primary modality Variable appearance IV contrast, 3-mm slice thickness, portal venous phase size, shape, presence and thickness of wall, septa, fat, calcification Acute- Heterogeneous, MR - Problem-solving tool High-attenuation on CT, T1 and fat-suppressed T1- Assess high-signal fat or hemorrhage Hyperintense on T1 and T2 T2 and fat-suppressed T2- lymphadenopathy, muscle invasion, cystic change or necrosis, fluid collections, bone marrow edema Chronic- Low-attenuation on CT Contrast-enhanced T1- Differentiate solid from cystic or necrotic Low signal on MR, hemosiderin lesions, extent, presence and nature of vascular thrombosis
604 Urinoma, Urine leak - CT- Water attenuation, 8 days post right nephrectomy progressively increased attenuation by contrast enhanced urine entering the collection on delayed excretory images Subacute Hemorrhage Commonly with proximal hydroureteronephrosis
Retroperitoneal Lymphocele - Collection of lymph without epithelial Fibrosis and lining, often seen post lymphadenectomy IgG4-Related Sclerosing CT- Homogenously low attenuation, Disease low attenuation fat can be seen SOLID Pseudotumoral NONNEOPLASTIC Lipomatosis
Histiocytosis PROCESSES Extramedullary Hematopoesis
Amyloidosis
RETROPERITONEAL FIBROSIS (RPF) RPF
Secondary: Idiopathic in more than 70% of cases. Drug-induced- Most common known cause of RPF is use of Methysergide (an ergot derivative) in treatment of migraine As many as 15% of patients have additional fibrotic process Inflammatory Aortic Aneurysm outside the retroperitoneum. Traumatic - Hematoma, Urinoma, Radiation, Surgery Infectious Granulomatous disorders Coexistence with autoimmune disorders such as IgG4 related Histiocytosis (Erdheim-Chester) sclerosing disorders, and response to steroids suggests Occupational –Asbestos autoimmune origin. Neoplastic - Desmoplastic to retroperitoneal tumor or paraneoplastic Endometriosis Amyloidosis
605 RPF-IMAGING RPF-IMAGING
Homogeneous soft-tissue below Medial deviation and tapering of middle third of the ureters at aortic bifurcation L4-5 level, proximal hydronephrosis
Encasing the aorta, IVC, eventually CT- Plaque typically has the same ureters, with hydroureteronephrosis attenuation as muscle Avid enhancement in the active, Does not displace the aorta and IVC Little or no enhancement anteriorly, as lymphoma or metastatic in chronic phase nodes often do
RPF- MR RPF-IMAGING- CT
Medial deviation Tapering of middle third of the ureters at L4-5 level Proximal Hydronephrosis RPF T2-Signal Enhancement Pathophysiology
Active Hyperintense Present Inflammatory edema > Plaque typically has the same cellularity Mature, or Isointense to low Less attenuation as muscle after steroid Decreased Edema therapy Malignant RPF Heterogeneously hyper Present Hypercellularity > edema
Goenka A H. Radiol Clin N Am 50 (2012) 333-355
RPF RPF
Mature or Post Treatment
Patient with RPF Increased left Axial T2 and para-aortic STIR Axial T1-WI signal with increased Low and intermediate signal intensity enhancement soft tissue encasing the retroperitoneal vessels and kidneys, Axial T1 pre and post Axial STIR 1 year later, post steroid Rx, decreased enhancement
606 18F-FDG-PET, and Gallium 67 Scintigraphy Isotope uptake parallels RPF activity Retroperitoneal Fibrosis Share the common Sclerosing Mesenteritis histopathologic findings of Autoimmune Pancreatitis, lymphoplasmocytic High uptake in the Active Stage Sclerosing Cholangitis inflammation with:
Little or no uptake in the Chronic Fibrotic Stage Inflammatory Pseudotumor CD4 or CD8-positive T- lymphocytes and IgG4-positive Detect Multi-focal fibro-inflammatory disease Fall under the umbrella of IgG4- plasma cells with interstitial related sclerosing diseases fibrosis.
Assess Therapeutic responce Radiographics 2013; 33:1053-1080 Elevated serum IgG4
Retroperitoneal Fibrosis Sclerosing Mesenteritis
Axial T1 post contrast- Pancreas, “sausage” shaped with multiple cortical lesions in R- kidney peripheral smooth hypoenhancing L- hydro, periaortic soft tissue rim, described in autoimmune encasing the left ureter pancreatitis,
MALIGNANT-RPF EXTRA MEDULLARY HEMATOPOIESIS
Malignancy- 8% of cases of RPF Hematopoietic deposits outside the bone marrow More common in liver, spleen and lymph nodes Retroperitoneum an uncommon site Desmoplastic response, In Hemoglobinopathies, Myelofibrosis, Paraneoplastic fibrosis Leukemia and Lymphoma
CT- lobular paravertebral mass Lymphoma is the most common with or without fat underlying malignancy, also sarcoma and carcinomas MR, variable, • T1 and T2 low signal due to hemosiderin • T1 and T2 high signal due to fat Imaging often suboptimal and • Enhancement, Variable often mild biopsy required Mesurolle B. AJR; 167, November 1996:1139-1140
607 PRIMARY RP NEOPLASMS MESODERMAL NEUROGENIC Primary RP Leiomyosarcoma Schwannoma, Neurofibroma, TUMORS Tumors Liposarcomas Malignant NS tumor Desmoid Ganglioneuroma, Pleomorphic Sarcoma (MFH) Ganglioneuroblastoma, Originating Lympangioma Neuroblastoma from RP Perivascular epithelioid cell tumor Paraganglioma, Pheochromocytoma Organs GERM CELL / SEX CORD LYMPHOID Germ cell tumor Lymphoma Metastasis Primary sex cord stromal tumor PTLD Plasmacytoma Castleman’s disease 70-80% of solid RP masses are malignant
MESODERMAL RP TUMORS: MESODERMAL RP TUMORS LIPOSARCOMA
Subtype Imaging features Sarcomas Well Differentiated • Macroscopic fat Desmoid • Streaky fibrous enhancement Lymphangioma Myxoid • Water attenuation myxoid components Perivascular epithelioid cell tumor (PEComa): • Gradual, reticular enhancement AML, clear cell sugar tumor, LAM Dedifferentiated • Contain fatty and solid components • Calcifications Pleomorphic/ • Little to no fat Round cell • Indistinguishable from other RP tumors
MESODERMAL RP TUMORS: WELL DIFFERENTIATED LIPOSARCOMA DDX: Macroscopic fat Large (>10cm) Well differentiated liposarcoma Well encapsulated Streaky, enhancing septae >2mm
Renal parenchymal defect (Beak sign) Feeding artery from kidney
Renal AML
608 WELL DIFFERENTIATED LIPOSARCOMA MESODERMAL RP TUMORS: DDX: MYXOID LIPOSARCOMA
• “Pseudocystic” myxoid component is fluid attenuation / signal but shows gradual enhancement
Adrenal Myelolipoma
MESODERMAL RP TUMORS: MESODERMAL RP MASS: DEDIFFERENTIATED LIPOSARCOMA LEIOMYOSARCOMA
Little to no fat Most common primary IVC May contain Calcifications tumor Indistinguishable from other RP tumors Large size >10 cm Necrosis common, hemorrhage 2/3 women
MESODERMAL RP MASS: GARDNER’S SYNDROME
FAP + extracolonic manifestations Skull osteomas Desmoid tumors (in 20%) Papillary thyroid cancer Skin lesions
24 year-old male with history of total colectomy
609 MESODERMAL RP MASS: WHAT IS FALSE FOR DESMOID TUMOR? LYMPHANGIOMA
• Simple or multiloculated A. Malignant tumor composed of fibrous tissue cystic mass B. Increased incidence in Gardner’s syndrome but • May have negative majority are sporadic attenuation on CT due to chyle C. A/W abdominal surgery, trauma & estrogen tx • May have calcifications D. Tendency to recur after surgery • Insinuates between normal structures
NEUROGENIC RP MASS:
Nerve Sheath Tumors: Schwannoma Neurofibroma Malignant NST: growth, pain, irregular / infiltrative, younger patients with NF-1: 50% Ganglion Cells: Ganglioneuroma, Ganglioneuroblastoma, Neuroblastoma Paraganglion Cells: Paraganglioma, Pheochromocytoma (adrenal medulla)
NEUROGENIC RP MASS: SCHWANNOMA NEUROGENIC RP MASS: SCHWANNOMA
F>M, 20-50yrs • Encapsulated, extend along nerve (paravertebral or presacral) • Large: Heterogeneous (cystic changes, Ca+, hemorrhage or myxoid stroma)
Small schwannomas are round and homogeneous
610 NEUROGENIC RP MASS: NEUROFIBROMA NEUROFIBROMA
M>F 20-40 yrs Target sign Isolated (90%) dense central area of Multiple: 100% NF-1 collagenous stroma Dumbbell shaped / Fusiform along course of nerve Low HU on CT (lipid) Atrophy of muscle supplied Widening of neural foramina and scalloping of vertebra
NEUROGENIC RP MASS: NEUROGENIC RP MASS: GANGLIONEUROMA PARAGANGLIOMA Benign Para-aortic (Zuckerkandl) 20-40 year 40% malignant 57% functional (catecholamines 40% functional or androgenic hormones) Fluid fluid level caused by Paravertebral, insinuate hemorrhage between normal structures Avid enhancement Speckled calcs in 20% Rarely lightbulb bright on T2! ‘Whirled’ appearance at MRI
NEUROGENIC RP MASS: PARAGANGLIOMA VON-HIPPEL LINDAU
RCC Renal cysts Pheochromocytoma Pancreas: serous cystadenomas and islet cell tumors (NOS subtype) Hemangioblastomas Retinal angiomas Endolymphatic sac tumors
611 GERM CELL / SEX CORD RP TUMORS GERM CELL / SEX CORD RP MASS: GERM CELL TUMOR
Germ cell tumor 1-2% of GCTs are Seminoma extragonadal NSGCT (Embryonal carcinoma, Yolk sac tumor, Most RP GCT are Choriocarcinoma, Teratoma) metastases from gonadal origin Primary sex cord stromal tumor Rare Testicular US in patient with RP mass suspicious Women for GC origin Non-specific imaging
GERM CELL / SEX CORD RP MASS: TERATOMA BURNED OUT GERM CELL TUMOR
Solid or cystic +/- Fat, Ca+ Fat-fluid level
LYMPHOID RP NEOPLASM: LYMPHOID RP TUMORS LYMPHOMA
Lymphoma • Most common RP PTLD malignancy Extramedullary Plasmacytoma • 20% of NHL may be heterogenous Castleman’s Disease • Surrounds structure w/o compressing (floating aorta)
612 PRIMARY RP NEOPLASMS: PATTERN OF SPREAD DIAGNOSTIC CLUES
Pattern of spread Lesions that extend between normal structures: Tumor characteristics (fat, solid/cystic, fluid-fluid levels, vascularity, Ca) Lymphangioma Younger age Ganglioneuroma Neurogenic tumors, Germ cell tumors, Lymphangioma, Lymphoma Desmoid Labs Neurofibroma Ganglioneuroma: 57% functional (catecholamines or androgens) Paraganglioma: 40% elevated catecholamines Germ cell tumor: elevated hCG and AFP
PRESENCE OF FAT PRESENCE OF MYXOID STROMA
Myxoid Sarcomas Lipoma Neurogenic tumors Liposarcoma Schwannoma Teratoma (may have fat-fluid level) Neurofibroma PEComa Ganglioneuroma (younger patients) EMH Gangioneuroblastoma Malignant nerve sheath tumor
TUMOR NECROSIS HYPERVASCULARITY
Sarcoma (esp. Leiomyosarcoma) Paragangliomas Paragangliomas Hemangiopericytomas May have fluid-fluid levels from hemorrhagic necrosis Sarcomas Castleman’s disease
613 CYSTIC COMPONENTS
Entirely cystic Lymphangioma Mucinous cystadenoma THANK YOU
Mixed solid and cystic Neurogenic tumors [email protected]
REFERENCES
Goenka AH MD, Shah S MD, Remer E MD. Imaging of the retroperitoneum. Radiology Clinics of America 50 (2012) 333-355. Rajiah P MBBS MD FRCR, Sinha R MD FRCR, Cuevas C MD, Dubinsky T MD, Bush WH Jr MD, Kolokythas O MD. Imaging of uncommon retroperitoneal masses. Radiographics 2011; 31:949-976. Murphey MD, Carroll JF, Flemming DJ, Pope TL, Gannon FH, Kransdorf MJ. From the archives of the AFIP: Benign musculoskeletal lipomatous lesions. Radiographics 2004; 24:1433-1466. Nishino, M MD, Hayakawa K MD, Minami M, MD, Yamamoto A MD, Ueda H MD, Takasu K MD. Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnosic clues. Radiographics 2003; 23:45-57.
614 615 616 617 618 619 620 621 622 623 624 Disclosures Pitfalls of imaging as related to IR • None procedures Acknowledge UCSD Partners: Hamed Aryafar MD Thomas Kinney, MS, MD Associate Clinical Professor of Anne Roberts, MD Vascular and Interventional Steven Rose, MD Isabel Newton, MD, PhD Radiology
Introduction Objective
• Interventional Radiology is often asked to review • Review some examples of potential pitfalls of imaging for possible intervention. pre-procedural imaging. – Frequently before any formal diagnosis is present. • Methods to alleviate potential problems that may • Outside referrals may often lead to incorrect arise. assumptions or diagnoses. • Mainly case based review
30 M with history of prior talc pleurodesis for Case 1 spontaneous left pneumothorax > 1 yr ago
T10
625 Current study CT imaging
Prior comparison Diagnostic Interpretation: 2 cm enhancing pleural based mass lesion T9 level Diagnostic consideration pseudoaneurysm related to prior chest tube placement in past. Recommend Neuro IR Consult
T9 T10 T11 T12 Formal Spinal Angiogram: Flush Thoracic Aortogram
Selective angiogram in search of tumor/ aneurysm
Celiac SMA
Pre and post Diagnosis: Talcoma Contrast CT scans • Talc pleurodesis is commonly used for the treatment of pleural effusions and recurrent spontaneous pneumothoraces • Following this procedure, pleural abnormalities are common and include pleural thickening, loculated effusions, nodules, and masses • Masses related to talc sclerosis are most commonly found in the posterior caudal aspects of the thorax: para- mediastinal or para-vertebral. • Characteristic high attenuation • FDG uptake has been noted in talc-related pleural disease (SUV may be >15 U)-which may mimic cancer (granulomatous reaction to talc)
* Avila NO, et al, AJR 2006; 186:1007-1012/ Murray JG, et al AJR 1997; 169:89-91
626 Case 2
• 46 M status post Stab Wound to the chest 1 week ago • Presents to ED with SOB • CT abdomen pelvis
More delayed
Treatment? Angiographic findings
• Embolize with coils? – Dense opacification of lesion • Embolize with gelfoam? – "Cotton wool" • Follow up CT in 1 month? appearance • Do nothing? • Pooling of contrast medium
627 Angiographic findings Case 3
– Normal-sized feeders • 69 F with RUQ pain – No neovascularity – No arteriovenous shunting – Typically retain contrast beyond venous phase
Dx: Hemagioma of the liver Venous malformation of the liver
Diagnosis: Acute Returns 2 months post laparascopic cholecystitis cholecystectomy with RUQ pain Treatment: Laparascopic cholecystectomy Dx: Post surgical abscess
After 2 weeks of antibiotics IR guided drainage recommended
• Persistent abscess
628 CT guided procedure
Diagnosis: Retained Gallstone post Case 4 surgery • Patient went back to surgery for removal of • 67 M with abdominal pain, concerning CT, stone. transferred from outside institution for care.
Emergent open surgical repair
• Retroperitoneal approach • Aortic reconstruction with graft. • Did not go through with complete Aorto-bi-iliac repair due to acute nature.
629 3 months later
• Patient returns to the emergency room with abdominal pain.
Diagnosis and treatment?
• Aortic endograft repair? • Repeat open surgical repair? • Put a needle into it?
Diagnosis:
• Anaplastic neoplasm without clear differentiation. Pathology favors sarcoma.
630 Elderly man Case 5 admitted with chronic SOB
Referred to IR for thoracentesis
Chest tube placement
• Pt’s symptoms never improved • Despite thoracentesis or chest tube • No change of pneumothorax • Despite using higher pleural evacuation pressures!
Companion case Diagnosis: Pneumothorax Ex vacuo
• Benign uncommon form of PTX Initially defined as condition in which acute bronchial obstruction and lobar collapse occurs and gas in drawn into the pleural space Now: refers to development of gas in pleural space because lung is unable to expand to fill the thoracic cavity after removal of fluid • Seen with malignant effusions (fibrous peel over visc pleura) • Patients have minimal symptoms • Chest tube may not evacuate PTX/ life expectancy often < 6 months
Acad Radiol 2005; 12:980-986[UCSF]/ AJR( Boland GW) 1998; 170:943-6
631 Case 6 53M with history of IV Drug Use
• Treated for bacteremia • TEE negative for endocarditis • CT abd/pelvis
Abscess vs Hematoma?
• Had vague history of a fall, pt was drunk and did not remember well. • Fluid collection was painful. • VIR consulted for aspiration/drainage.
VIR aspiration Diagnosis: Morel Lavallee
• Fluid was serosanginous, non-purulent, thin.
632 Case 7
• Can recur • Tx: Aspiration +/- compression • May need surgical resection of capsule
Elderly male with left flank pain, ↑ WBC Xanthogranulomatous Pyelonephritis
5th –7th decade, Female > Male Diffuse (90%), Segmental Plasma cells + lipid-laden macrophages (xanthoma cells) Anemia (70%), elevated LFT’s (25%), diabetes (10%) Enlarged, malfunctioning kidney with central obstructing calculus DDx: hydronephrosis, avascular tumor
Potential Pitfall: XGP http://www.webpathology.com/
Pt with history of Ethanol abuse Case 8 admitted with nausea, and abdominal pain. History of pancreatitis
Dx: Large pancreatic pseudocyst Plan: Drainage
633 Post drainage: Pt doing worse, septic Left upper quadrant drain added with peritonitis. Reimaged that night. Diagnosis: Gastric outlet obstruction. -Patient could have been treated with Reformat of original CT: NG Tube alone. -Without gastropexy, he spilled gastric contents into peritoneal space. -Was eventually stabilized by supportive care, NGT, and additional drainage of leaked gastric contents.
Dx: Apparent spill from the pseudocyst Consult: consider adding additional drainage catheter to drain spilled material
Case 9
• 88 M with hematuria, renal failure, hydronephrosis 19201904
IMPRESSION: 4.7 x 3.3 x 5.8 cm right pelvic mass. CT pelvis with contrast is recommended for further evaluation. Consult IR for Biopsy
Further evaluation requested
634 Diagnosis: Bladder diverticulum Case 10
• Secondary to increased intra-vesicular pressure • 56 F with cirrhosis of unclear origin • Result from BPH, urethral stricture, bladder neck • Followed by hepatology for portal hypertension contracture • Request for TIPS procedure for portal • Most often Males, > 55 years of age decompression • Location: typically solitary along lateral wall of bladder • Most are asymptomatic, some associated with GU anomalies ; malignancy can occur in 1-10% of bladder diverticula
8 Months earlier
1 year earlier
• Portal-systemic gradient 22 mmHg
Post 5 different embolization procedures
Dx: Pseudoaneurysm related to prior biopsy
635 Post embolization Case 11
• Symptoms (recurrent ascites) improved, but did not resolve • Hepatopetal flow (instead of hepatofugal) • Patient currently listed for transplant, TIPS contra-indicated.
• 44 y/o M with gradual onset left upper abdominal/left flank pain described as a fullness along his flank over the course of a month. • Pain rated 7-8/10. • Denies f/c/n/v, denies dyuria.
636 Hydroureter: consult for percutaneous nephrostomy for decompression
637 638 Post-procedural Course MRI Lumbar Spine 3 years ago
• Patient with initial improvement immediately following the procedure, followed by recurrent pain and fullness in left upper abdomen/flank. • eGFR stable at 76 ml/min • Urine gram stain and culture negative
Diagnosis: Congenital Megaureter
• Dilated ureter (> 6 mm) tapers to normal caliber just proximal to bladder • Left side more common • Tc-99m-DTPA renography → early stasis pattern, prompt washout after diuresis.
Differential diagnosis: Etiology • Obstructive Hydronephrosis – Both medulla and cortex become atrophic; no polycalyces • Megaureter – Evidence of obstruction, intrinsic (e.g., stones, tumor) or extrinsic (e.g., retroperitoneal fibrosis or tumor) – Adynamic distal ureteral segment, which has normal • Post-obstructive Atrophy: Residual dilatation after caliber chronic obstruction – Excess collagen and fibrosis; deficient or disordered – History helps to differentiate from megacalices/ureter muscle in wall of distal ureter • Postoperative Pyeloplasty • Vesicoureteral Reflux – Grade 3-5 reflux may cause irreversible dilatation of ureters and calyces – Best shown on VCUG – Tortuous dilated ureter; no "adynamic" juxtavesical segment • Renal Papillary Necrosis – Usually 1 to several sloughed papillae – Club-shaped calyces
639 Treatment Case 12 (final)
• Surgery performed in 20-30% of cases: Excision of • 48 M with metastatic colon cancer responding to juxtavesical segment and ureteroneocystostomy chemotherapy. • Evaluate for progression of disease
Biopsy results: benign Consult IR for biopsy inflammatory tissue
Review of the imaging: Diagnosis: Pulmonary infarct
• Occurs in a minority of patients (less than 15%) • Usually associated with small vessel occlusion (< 3 mm) • Wedged shaped pleurally based without air bronchograms • Usually in the lower lobes
640 Conclusion Thank you!
• Beware of diagnoses that can lead to IR procedures • Enlist help of others as needed • Understand the diagnosis first before undertaking therapy (review prior imaging!) • Hopefully review of these cases will help you stay out of trouble • Good luck!!!
641 642 643 644 $!$(#$
• &)$!#%!%#,#. 0 • ! ,#/ !!( #!$%! !# $$! $#! ! +"# % %#!)# !#%!#$
+ # !#$ . #!$$!# #!!!,
30
%$(!%
• *,$!)#$& %% %%* !(# % +%%*!,#$ ( #$& %% %%*!(# 1976: 450 BHP, 190 MPH, $500,000* % +%% 0! 1%%,!(#$( %! &! 0
2012: 1184 BHP, 267 MPH, $2,700,000 *$2,057,613.17 in 2013$
%!#! %
• "#! $!! ! !!$ $#)$"%(#$$($% %#$%. ) * ( #$!
38 BHP, 65 MPH, $2,951 How much is a Nissan Versa? $12,780
645 ',** History of airline regulation (1978) and the CAB Adjusted $
Since 1938, the federal Civil Aeronautics Board (CAB) had regulated all domestic interstate air transport routes as a public utility, setting 896 fares, routes, and schedules. Airlines that flew only intrastate routes, however, were not regulated by the CAB. Those airlines were regulated by the governments of the states in which they operated. The CAB promoted air travel, for instance by generally attempting to hold fares down in the short-haul market, to be subsidized by higher fares in the long-haul market. The CAB also was obliged to ensure that the airlines had a reasonable rate of return.
2,622
Wikipedia: http://en.wikipedia.org/wiki/Airline_Deregulation_Act
2,775 http://paleofuture.gizmodo.com/air-travel-today-is-a-damn-bargain-951705216
33 Airline Chapter 11 Bankruptcies since 1978 Thursday, October 17, 2013 American Airlines Reports Most Profitable Quarter in Company History
Airline Airline Woodrow Bellamy III
New York Airways Air Canada American Airlines parent company AMR Corp., on Thursday reported a net profit of $530 Aeroamerica Flash Airlines million for the third quarter of 2013, the most profitable quarter in its company's history. Florida Airlines US Airways Air Bahia Aloha Airlines The net profit was a $420 million year-over-year improvement for AMR Corp., and also came Mountain West Airlines-Idaho Northwest Airlines with revenue of $6.8 billion, the highest quarterly revenue ever reported by the American LANICA Delta Air Lines Airlines parent. The report comes as American and US Airways Group prepare to defend Air Pennsylvania Aloha Airlines their proposed merger against a lawsuit filed by the Department of Justice (DoJ).
Cochise Airlines ATA Airlines Aero Virgin Islands Skybus Airlines "We are pleased to report our highest quarterly net profit in American's history, excluding Altair Airlines Frontier Airlines reorganization and special items," said Tom Horton, chairman and CEO of AMR Corp. Partnair Eos Airlines "Continued execution on our product, network and alliance strategy, combined with cost Pan American World Airways Sun Country Airlines efficiencies from restructuring and fleet renewal, creates strong momentum towards our America West Airlines Primaris Airlines planned merger with US Airways. And we are especially pleased to set aside $59 million this Trans World Airlines Mesa Airlines quarter in expectation of making our first profit-sharing payout since 2001 to our people who US Airways Arrow Air have done so much to put American back on top." United Airlines Mexicana American Airlines American took delivery of ten Airbus A319s, eight Boeing 737-800s and one Boeing 777-300ER during the third quarter.
If American and US Airways as American Airlines Group largest airline by revenue and profit, with earnings of >$40 Billion.
Related: Aviation Today's Checklist
• " (&'&!() ! (&/ $+*#
646 ' &$!&'! !$$&
• *$ &!+$!$"$5-%' ! '! %6 • * %& $%!$"!% • +* &6 • & %*$ - %6 • %*%%!$=< &$!*'! !*'! % • >< &%5 +* &5 "!.$ • % ,& %&&&%&B?.% • =<&!A< "!.% • &$"*$% %*$ !$"." &. – $!+&$!+$ – % !"$%! - "'! ! %&&&-% • >AK! "!.% $! – 9=1>=>"$.$ ><==1LJ!"%& %*$ • ??K!!%&%!+$ • & &!$%%3!"&5!*&4&$&% – &$ '+9>EA" &."$ "!. – ><AK! "!.% $!??K!!%&%!+$ – "$ &5"!. *%! *"* '>A.$%! – %! &%! *'%1 &%1 "% • CAK! "!.% $! 647 %(,""" & &&+&*&#""'#% • #,%"!"'6&"$+%&"."& • + +'#%'/ • %,' '"&+%"#"'%# • %-'%(""#,%&" – % '%#% " &%"" F;?:D – #% , &#% (0"& • # +(#"& – #!!#"- '# – #!!#"- '% #!!#"- '% #!!#"- '# • +&0 • "&+&0 • ",+ &"! &%""F=::D • ",+ &"! &%""G=::D • # %.&(" $%#+'& • #+''#"&+%","#%&2@ , '%#+ && ' $%($' – "#>$%#+'(%&-'$$%#$%' +( &"#$/& – %'$%"#8 "#!$"&'% ## #% "%"'& • A::! #"8"<::@ • .$"&#" – $ '''5& • &$%#$#%(#"'&%+"" • E+$'#=::D# (%&+&& – ;?: " • #$& – 8>::55!#"' – %"&#!$"&' • E+$'#>::D# (%&+&& – +% #$' & $"'$##%-%" ' • (#" &+&& • 3+&'6"6(!4$# &#% &'!"+'& "#"6 "%# 648 *!# $$)$($! &! $5= *!# $$)$($! &! $5> • C%+%$%$%% • %#$#$% "!-# • % $ "!")&! !B1@ ! • B !# %#$ • * !*#$%#)&! !+% • >! %$"#!"!#&! %$#!$"%$ • %#! )&! %# )$%#$ • $%$)$.! ) %-% %# • !+ ) #! # %$ %+!# – !)!%#+$#% &! )# )%! #"- % %- *!# $$)$($! &! 5? ) # %$!#%" • "!-#$)$.&! ! "!- • #$ %! $) #"- % %# ><<H %# %3%4 - %5= %# %3%4 - %5> • 5$," $# • ,"%&! $!#"- % • ><=B – #! <5DH!#!$$ ! – 9==0DD< *)$ – !"- %)"%!=A 649 &(*#!*1 % )(&$%1( $'#$%*+&% • &(*#!*1!%DB:HF15&5DBBC:DBBG&$'(/!* DBBI:DBCB • .)5'(&'%)!*1)&(:%&%*( (&-' • ()##:-)$&(*#!*1&D5KN )-#*) • ()7 #* ($%#8* )1F5GN • )-*()&J5D* )'(CBB3BBB • % )#( (!%&-%+)/!* #&/( &-) !%&$) Ann Internal Med. 2014;160(9):585-593 &)*&.!% !.)/!* &$%1( $!))!&%*) • %%#)!% %*(%# !!% &(*#!*1(+#%#1)!) • 1'&* )!)4EB1($!))!&%);CFN</&-##)) %&$$%*(1;(+# CJHIBGB< /!* !$'(&. #* ()) • &(.(1JEB-#*) !%!% !%)-(%3C/(* '(1( • &$'('(%'&)*/!* = .(1 – ))-$$'#&1()'&%)&(&.( !% )?G3BBB )#! *;B5DN<!%()3 '(&.(3''(&0!$*#1?F3BBB3BBB'(#!). – 7&)*:+.%))8#-#+&%))- )*%*&' • G$&)*&$$&%($!))!&%&%!+&%) 1(&#!).)%&$&(* %E0%+&%6)'(: – &&9')1 &)!) '!* – "'!% – (&(3$&(*#!*1 !%&EB1('(!+&%##! ).) &-# !% – )*'!%9 – &.!)-%(#!)+ !.%* &!%!.!-#)/ &) – -)*%-) #!.)(*1'!##1).!%)- ) $ – "!%!%+&% Lasser et al., BMJ 2014;348:g2329 Michael Cannon, Forbes Online; 5/5/2014 $'#&1(:)-#*) &'-#+&%:)-#*) • $'#&1(:)&.( • GEB3BBB-%!%)-(!%DBBH – DBBGOIBN&.( • CDB3BBB-%!%)-(!%DBCC – DBCBOIIN&.( • -'(!)!% ()-#*40##%*&$'#!%3 * (&(%&*$- '%#*1$&%1 %(* 650 # #(,'$-'(,!)(9C # #(,'$-'(,!)(9D • '$"CBQ$.#)$EQ:$% #DDQ$.#)$JQ; • HJQ$#.!0 #(,'- !0$'$"%!)!0)/%0' – #-# ()' ,*$#$'% !!0#0$(% )!:44< CCQ; (,( 1 – P$)EQ (,#$,"#)8,# #(,' • • ''%$$!$.#RGBQ3'$"IBB )$EBB 3. )'()' )%0$,)( RGBQ$#.FBJ3BBB #(,'%0#$) # • $(#$)'(((()$'$'$()$' • CFB3BBB,# #(,' #DBBJ )'%#! 1$' /"%),)$6 # ! )0)$%07 '9 ' ,'#' 'CH3DBCB '9 ' ,'#' 'CH3DBCB !)'$()(9(,!)(9C !)'$()(9(,!)(9D • $!$#'"$()/%#( - • -'" !0$F>CE3IJJ##,!!0 – K)%! #!.'3 !! #$ (3 .$' 3 – ($) $()$! - ##.( $ (!#3$##*,)3!$' 3 . – (%'$%$'*$#)) #$(% )!%'(# # "%( '3#) ()' )$$!," )?C ,')'' -(,%$()( • *!!/%#( - • $()('#$)$#)'$!!30DBDB-' – DIQ$-#*$#!"# " !0$F. !!%0>DH3BBB – (')')')##*$#!-' – DBBK!$#CB4EQ #'( '9 ' ,'#' 'CH3DBCB ## !,'#(,!)( ##* %)$#(&,#( • -'GBQ$)#.!0 #(,'%0#$) # • !*-*$#$$""$#.!)' #'(,( 10)/%0'( %*#)( • ' "'0'($'):($,!#5)-# (,'%' (; • #!)0%$$!(# • )( 651 "#&&(''+!$)#"'7= "#&&(''+!$)#"'7> • "&'"G#"'+&&'+ ('"#'(#"( ' • /'"'-($(/-#+ - #!$)"(' – "'+&$)"('&!#& /(#' $&!&/ -(#!!#"- (&"#!!#"- ( "!+ (#&/&&(&("!&"/ #""(#&$/!"(#$)#"' $&(!"(,'(' • )"('-(#!!#"- (#""(#&#$)#"' • &'$ "(/#$&!&/"!+ (#&/ -#+ '"'&+ &&7&&/""'+& $)"(' &$(/ /-#+ "6(#""(#&#$)#"'- #!1 &!&/7&#&( • B>"('#"(# &&!+&'#&( • .$""'+&"2"#(#!!"'+&( #-'(&"#$)#"' .$"'#""$/'"' • $)"#!!#"- (& • ABG#"(&"'(' #'(#"-$)"(' – @?G#"(&"'(' • @@/',&-)")!#&$&!&/& – ABG#! /$&))#"&' • (/>7@G""+ "&'",'(' • $)"#!!#"- (# – A &!+!#"( 7= &!+!#"( 7> • &!+!"&'&%+'('/"'+&"#!$"' • "&'"'+&"#"( !"'"&' CG7?>G &+ )#" – ! +'"''&(' #-(#&+$(# $",+ 7$# /#'(' #-" – '2+&'#"( 2 )#"#,&'(2"& • (/# &7!$ #/&&(7(',# "(&'5 • ((8#,&"#&, (& 9-"('@4CG$ • #'('#"6('$$&3#&',"'H#'( – +&&"( /"(#-&'" (!.!+!844D4DG9 '" &7 &+&"& &=B2><=< &7 &+&"& &=B2><=< 652 -#$ 2 -# $!%$ 2 • $ $@>H #$ +% #/ • -%+%$ # ,$%$$ ?==B 3$$%# +$/ • +%#$$ !!# .%/D8>=H – EA $!%$ >ED=$ $ ?==B $ – BA+## % $!%$ • +% #$$ #$ – ## – # ## ,% ##$ / $+$/+%$ -# $+# ! $ 2 -# $%$ 2 • +$%#) C==H $$ • ,#$$&$& #%$- !# !%9:#"+# ,$ $+# -% %#!/$ $ %#, & • $%!$$$& !/$ $## – IH #$#,$ -#&,% $0 +% +$ $$ • %$% #% !/$ $ • ?==8@A=$ - • @A=8A==$+ • $%# . +$244 • A==8C==$ – ??H $$+$($!/$ $.!#$$%# – #$+%$ !/$ #!# %& 9$+ %#$% , & $ 5% 3 $ + & : + +# ,#%!$%>=/#$ .% $%!$8> .% $%!$8? • • +%$/$% – & $ #$/$% – ! %! #,- – - +6!/#7$/$% • $%$ • &/$%%A8/#& + #, %# • $ • %8- • 8- 653 8'%"+#+'" "/ '&'" 2 • ( 0("!"!'%" ,&5 • !'%' '% • . + 8'%"+#+'-' . + &'/ • #%", '% • !%&",% • #% '% 6&-3=;<;HI=;<@ 6&-3=;<;HI=;<@ • !%!'& • %("!! '%!!&! – !&+%! %'%"% =;<; – !! &&&'!"%",% – %#"%'< JAMA 2016;316(5):525-532 " "!'&8< " "!'&8= • DCG!&+%!",%" &&+&*&%&!'& • %%H +%"&&7 + &'&'!'!("! – &4>;5>G!"!- #(!'&#' • &&+&*&#"&&&&&&,% +!$+ • #% %/%&/&' &!+! '" %'%&(&- ''&+( '/&'&' &'#! • !!+ ?G '%"&'!%&&% ! • ""%!("!"%&!"' #%", • .#/%&&&+ '+%!"#/!"% +!!&+% • %"&& ! !'&!"' #%", • "%#,%("!&&( 654 655 656 657 658 Disclosure Cold Foot – Peripheral vascular • None disease for the diagnostic radiologist Hamed Aryafar MD Associate Professor of Radiology/ Interventional Radiology Topics Topics • Background • Background • Non invasive testing • Non invasive testing – Segmental pressures/ pulse volume – Segmental pressures/ pulse volume recordings recordings – Ultrasound – Ultrasound – TCPO2 test – TCPO2 test PAD Risk Factors • Male sex • Increased risk of • Increasing age developing lower – ≥70 years extremity PAD with – 50-69 years and history of smoking or – Smoking: 2- to 6-fold diabetes – Diabetes: 2- to 4-fold – <50 years, with – High cholesterol: 1- to 2- diabetes and one other fold atherosclerosis risk – Hypertension: 1.5- to 2.5- factor fold • Alcohol use – Hyperhomocystinemia: 2- • BMI ≥25 to 3-fold • Family history – C-reactive protein: 2-fold Gandhi S, et al. Prog Cardiovasc Dis. 2011;54:2-13. Hirsch AT, et al. ACC/AHA 2005 Practice PAD guidelines. Circulation. 2006; 113:e463-e654. 659 PVD in United States Clinical Manifestations of PVD 12 10 8 • Asymptomatic 6 • Intermittent claudication Americans 4 • Chronic limb ischemia (millions) 2 0 PVD PVD with PVD w int. claud CAD As US demographics change to older population PVD may be more prevalent Intermittent Claudication Claudication or not? • Aching, pain, tiredness, tightness, cramping in the buttocks, thigh, calf, or foot brought on by exercise and relieved by rest – Reproducible with a consistent level of exercise from day to day – Completely resolves within 10 minutes after exercise stops – Occurs again at the same distance once walking resumes – “Angina of the leg” PAD Signs, Symptoms, and PAD Signs, Symptoms, and Complications (cont) Complications (cont) • Rest pain • Ischemic ulceration and gangrene – Pain on the dorsum of the foot or deep in the forefoot – Ischemia severe enough to cause tissue loss without exertion due to ischemia at rest – Thought to be the natural endpoint to rest pain – Often occurs at night and awakens patients – High risk for limb loss – Can be relieved by dangling the foot over the edge of – Together with rest pain, considered critical limb the bed (gravity) ischemia (CLI) – “Unstable angina of the foot” – “Acute myocardial infarction (MI) of the foot” 660 High Resistance Arterial Systems Low Resistance Arterial Systems High tone at rest, capacity for increase Organs that need constant blood supply e.g., carotid & renal arteries e.g., Musculoskeletal arteries Monophasic waveform Dicrotic notch No reversal in diastole ( Pressure ) Pressure Triphasic waveform = velocity Reversal early diastole = volume flow ( Vel & Vol ) Courtesy of Steve Rose Courtesy of Steve Rose Effect of Stenosis Effect of Stenosis Continuity Principle: In an unbranching conduit, Energy losses (heat) rise exponentially the volume of blood flow must remain constant with increasing stenosis severity at all points along the course of the conduit. Critical stenosis: If a reduction in lumen diameter ( stenosis ), Approx 50% diameter then velocity must increase proportionately Approx 75% area to maintain constant volume of flow. Courtesy of Steve Rose Courtesy of Steve Rose Topics Vascular Lab Testing for PAD • Background • Interpretation of ABI – >1.30 = Non-compressible vessels • Non invasive testing – 0.91 - 1.30 = Normal – ≤0.90 = Abnormal – Segmental pressures/ pulse volume • 0.5 - 0.90 = Mild-to-moderate PAD recordings • 0.00 - 0.50 = Severe PAD – Ultrasound • Claudication can occur anywhere from 0.1-1.0 – <0.5 is consistent with CLI – TCPO2 test – “One level of disease” can decrease ABI by 0.3 Rooke W, et al. 2011 ACC/AHA PAD guidelines update. J Am Coll Cardiol. 2011;58(19):2020-2045. Hirsch AT, et al. ACC/AHA 2005 PAD guidelines. Circulation. 2006; 113:e463-e654. TASC Working Group. J Vasc Surg. 2000;31(suppl 1):S66-S67. 661 Vascular Lab Testing for PAD (cont) Doppler Waveforms (Velocity) Noninvasive Exam ABIs and Doppler Waveforms Upstream occlusive disease - Adjunct to segmental P’s Normal: Triphasic High resistance Abnormal: Monophasic Low resistance Courtesy of Steve Rose Vascular Lab Testing for PAD (cont) Vascular Lab Testing for PAD (cont) • Toe pressures • Pulse volume recordings (PVRs) – Systolic BP in the great toe – Waveforms showing the quality of the pulse wave at – Predictive of ability to heal different levels of the leg – Normal is >60 mm Hg (ideally >80 mm Hg in – Suggestive of the location/severity of blockage diabetics) • Exercise ABIs – Important adjunct in patients with diabetes (non- – Analogous to a treadmill test compressible tibial arteries from calcification) – Only necessary for patient with a convincing history • Segmental pressures but normal ABIs at rest – BP measurements at several locations along the leg – Suggestive of location of blockage Hirsch AT, et al. ACC/AHA 2005 PAD guidelines. Circulation. 2006;113:e463-e654. TASC Working Group. J Vasc Surg. 2000;31(suppl 1):S66-S67. Hirsch AT, et al. ACC/AHA 2005 PAD guidelines. Circulation. 2006;113:e463-e654. TASC Working Group. J Vasc Surg. 2000;31(suppl 1):S66-S67. Pulse Volume Recording (PVRs) PVR Pneumatic cuffs thigh, calf, ankle Approx. 65 mmHg Volume changes converted to electrical signal - Plethysmography - Arterial inflow Not affected by calcified arteries - Useful in diabetics with medial calcinosis 662 Exercise Stress Test • PVR Normal Abnormal Exercise until pain - Treadmill, toe stands Measure ABI’s q 30 sec Positive: > 20% drop ABI or 20 mmHg drop Below baseline > 2 min Courtesy of Steve Rose Courtesy of Steve Rose Topics • Background • Non invasive testing – Segmental pressures/ pulse volume recordings – Ultrasound – TCPO2 test 663 Ultrasound Spectral Display • Inexpensive • Widely available tool X axis = Time Y axis = Velocity ( or f ) of • No real risks (ionizing radiation, contrast, etc) Δ given RBC’s @ specific • Does require expertise (Vascular technologist) moment in time Limitations: Brightness = Number of RBC’s Poor acoustic penetration moving @ specific velocity @ Bone given moment in time Air Excessive fat Small field of view (+/- 5 cms ) Operator dependent Courtesy of Steve Rose Angle of Doppler insonation Grey Scale • Detects US frequency shifts caused by reflection from moving RBC’s • Remember that Doppler is only accurate at or less than 60 degrees Color flow Normal Spectral tracing • Triphasic • Reversal of flow during diastole • Peak Velocities not markedly elevated (ratio more important than absolute) 664 AbNormal Spectral tracing AbNormal Spectral tracing At STENOSIS Immediately After • PSV 2 X or more of stenosis proximal segment • Parvus Tardus (loss • Spectral broadening of upstroke) • Aliasing • Diastolic flow (if collaterals present) • Turbulent flow • Biphasic AbNormal Spectral tracing Bypass Graft evaluation Downstream • PSV 2X indicative of stenosis • Monophasic • PSV < 45 cm/s worrisome for • Poor upstroke impending thrombosis • No diastolic flow • Will not always have traditional triphasic waveform (biphasic • Poor velocities normal) • Should evaluate inflow, anastomosis, and outflow Topics Transcutaneous Oxygen Tension (TcPO2) • Background Known advanced PAD • Non invasive testing – Segmental pressures/ pulse volume Tissue healing: recordings - Amputation level - Healing ulcers – Ultrasound – TCPO2 test Combined with ankle, toe B/Ps Courtesy of Steve Rose 665 Conclusions: TcPO2 Recording • Be familiar with non invasive testing methods Cathode – anode available Occlusive seal • Become Vascular certified if you do enough Free O2 diffuses through skin volume Electrical current • Understand the clinical aspect of the PAD to Good prognosis: better interpret the studies - Baseline 20 mmHg • Non invasive labs can provide revenue through additional imaging (CTA, MRA) and procedures - Rise after O by 10 mmHg 2 (IR, vascular surgery, cardiology) Courtesy of Steve Rose 666 667 668 SAVE THE DATE Hotel Del Coronado • Coronado, California 43 rd Annual Post Graduate Radiology Course October 22 – 26, 2018 20 th Annual Breast Imaging and Interventions Update October 26 - 28, 2018